Page last updated: 2024-11-07

dibenzylchlorethamine and Neuroblastoma

dibenzylchlorethamine has been researched along with Neuroblastoma in 2 studies

Dibenzylchlorethamine: An alpha adrenergic antagonist.

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Fakahany, E2
Richelson, E2
Lopez, JR1

Other Studies

2 other studies available for dibenzylchlorethamine and Neuroblastoma

ArticleYear
Phenoxybenzamine and dibenamine interactions with calcium channel effectors of the muscarinic receptor.
    Molecular pharmacology, 1981, Volume: 20, Issue:3

    Topics: Animals; Binding, Competitive; Calcium; Carbachol; Cells, Cultured; Cyclic GMP; Dibenzylchlorethamin

1981
Lanthanum binding to murine neuroblastoma cells.
    Journal of neurochemistry, 1983, Volume: 40, Issue:6

    Topics: Animals; Atropine; Carbachol; Cell Line; Cell Membrane; Dibenzylchlorethamine; Electron Probe Microa

1983